2017 Melbourne Immunotherapy Network half day symposium & NK cell Workshop

Event Information

Share this event

Date and Time



Walter & Eliza Hall Institute, Davis Auditorium

1G Royal Parade

Parkville, Vic 3052


View Map

Friends Who Are Going
Event description


The Melbourne Immunotherapy Network brings together basic and clinical researchers, with an interest in immunotherapy, from Institutes/ Universities/ Hospitals in and around Melbourne. We are pleased to announce the second annual MIN symposium as a morning event, followed by an NK cell workshop as an afternoon event, both held at WEHI in the Davis Auditorium on 24th November. To confirm attendence at the NK worskshop please RSVP separately to:

At this years symposium we are planning to run three sessions. The first will have key note speakers from each of the seven HUBs present research findings highlighting the technological and/or clinical capabilities of their institute/Uni/Hospital. The second session will be open to early/mid/senior post-docs from each HUB to present recent research findings. In the third session we will run a panel discussion on the challenges associated with the clinical study of immunotherapy and running of informative translational studies.

MIN Annual Immunotherapy Symposium. Organisers - MIN Committee.

Sponsored by Genesearch and WEHI

Provisional Program:

8:30 Arrival

9:00 – Opening Statements Prof Dale Godfrey (PDI; MIN Chair)

Session I (12 min talks, 3min Qs)

9:05 – Jonathan Cebon (Medical Director, ONJCRI Head, Cancer Immunobiology Lab)

9:20 – Nick Huntington (Laboratory Head, Molecular Immunology Division, WEHI)

Title: Emerging strategies to target NK cell in cancer immunotherapy

9:35 – Sherene Loi (Medical Oncologist, Group Leader, Peter MacCallum Cancer Centre)

9:50 – David Ritchie (Haematologist, Head of Allogeneic Stem Cell Transplantation, RMH)

10:05 – Fabienne MacKay (Head of School of Biomedical Sciences, Uni Melb)

10:20 – Robyn O’Hehir (Head, Allergy, Clinical Immunology and Respiratory Med, Monash Uni)

Title: Thunderstorm asthma: averting another strike by allergen immunotherapy.

10:35 – Daniel Gray (Laboratory Head, Molecular Genetics and Cancer Immunology, WEHI)

10:50 – Morning Tea

Session II (8 min talks, 2min Qs).

11:10 – Ashleigh Poh (Postdoctoral Scientist, ONJCRI)

Title: Inhibition of the myeloid-specific kinase HCK impairs tumour progression and metastasis

11:20 – Edwin Hawkins (Laboratory Head, Immunology, WEHI)

11:30 – Clare Slaney (Postdoctoral Scientist, Peter MacCallum Cancer Centre)

Title: Dual-specific T cells and an indirect vaccine eradicate large solid tumours.

11:40 – Thomas Gebhardt (Research Fellow, Peter Doherty Institute)

11:50 – Brendon Jenkins (Research Group Head, Cancer and Immune Signalling, Hudson/Monash Uni)

12:00 – Joanne Davis (Postdoctoral Scientist, Royal Melbourne Hospital)

Title: Targeting NK cells via BCL2 inhibition improves stem cell transplant outcomes in mice.

12:10 – Balasubramanian Krishnamurthy (Postdoctoral Scientist, St Vincent’s Hospital)

Title: Immunotherapy and autoimmunity

12:20 – Marian Burr (Postdoctoral Scientist, Peter MacCallum Cancer Centre)

Title: CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Session III

12:30 – Panel Discussion

Challenges for the clinical study of immunotherapy and running of human translational work.

Panellists: Sherene Loi, Paul Neeson, Johnathan Cebon, Oliver Klein, David Ritchie, Fabienne

MacKay, Robyn O’Hehir, Daniel Gray)

12:55 – Closing Statements (Dale Godfrey, MIN Chair, PDI)

NK Workshop

Sponsored by Diagenode

Organisers - Fernando Guimaraes & Karen Sheppard.

To attend to the workshop, please RSVP to:

1:45 - Arrival/Registration

1:55 - Welcome address

2:00 - Fernando Guimaraes – WEHI: NK cell transdifferentiation and it’s implication in cancer.

2:15 - Grant McArthur – PeterMac: State of play with melanoma therapies.

2:30 - Dan Andrews – Monash: The role of NFkB family members in the development and activation of NK cells

2:45 - Nick Huntington – WEHI: Drugging the NK cell-tumour interactome. Altered-self, cytokines & checkpoints

3:00 - Laura Dagley – WEHI: Proteomics and NK cell research: opportunities and challenges

3:15 - Coffee Break

3:45 - Joseph Sun - MSKCC, USA: Dichotomous role of NK cells in cancer and metabolic disease

4:30 - Jane Oliaro – PeterMac: A novel combination therapy to promote tumour cell death via cytotoxic lymphocyte-derived TNF

4:45 - Mariapia Degli-Esposti – LEI, Perth: NK cells in health and disease.

5-6pm: Drinks and social gathering

Share with friends

Date and Time


Walter & Eliza Hall Institute, Davis Auditorium

1G Royal Parade

Parkville, Vic 3052


View Map

Save This Event

Event Saved